Lineage Cell Therapeutics (NYSE American: LCTX) Q3 2026 Earnings Call
Lineage Cell Therapeutics (NYSE American: LCTX) reports Q3 2026 results on this call. Live coverage runs here, and the full replay with transcript and chapters lands on this page after the call.
- Company
- Lineage Cell Therapeutics, Inc. (AMEX:LCTX)
- Period
- Q3 2026 earnings call
- Date
- Thu, Nov 12, 2026, 4:30 PM ET
On 6ix: 6ix.com/event/lineage-cell-therapeutics-inc-lctx-q3-2026-earnings-call
Latest news releases
- NYSE American: LCTX — Lineage Provides Update on ReSonance® Program for Hearing Loss · Thu, Oct 29, 2026
- NYSE American: LCTX — Lineage Cell Therapeutics Announces Issuance of Patent Underlying Its AlloSCOPE™ 5D Manufacturing Platform · Tue, Sep 8, 2026